#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13970	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2170	640.1	0	.	n	.	0	A69G	SNP	69	69	A	322	322	G	743	G,A	708,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13970	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2170	640.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1703	1703	T	791	T,C	742,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13970	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2170	640.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	896	C	849	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25842	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3603	715.4	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	808	C	764	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25842	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3603	715.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	848	C	785	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25842	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3603	715.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	837	A	813	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25842	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3603	715.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	876	C	828	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2124	folP	855	855	100.0	folP.l15.c4.ctg.1	1500	140.8	1	SNP	p	R229S	1	.	.	685	687	AGC	991	993	AGC	205;208;211	A;G;C	194;197;197	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3315	164.2	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	193;194;190	T;T;C	182;185;183	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3315	164.2	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	180;179;178	G,T;G,A;C	174,1;171,1;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3315	164.2	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	180;179;178	G,T;G,A;C	174,1;171,1;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1704	mtrR	633	633	99.84	mtrR.l6.c17.ctg.1	1340	126.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	621	623	AAT	195;195;196	A;A;T	185;185;185	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1704	mtrR	633	633	99.84	mtrR.l6.c17.ctg.1	1340	126.6	1	SNP	p	G45D	0	.	.	133	135	GGC	519	521	GGC	243;243;244	G;G;C	232;233;229	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	926	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1093	84.2	0	.	n	.	0	A197.	DEL	197	197	A	619	619	A	208	A	200	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	0	.	p	.	0	E91G	NONSYN	271	273	GAG	602	604	GGG	198;199;199	G;G,A;G	189;188,1;187	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	1	SNP	p	D86N	0	.	.	256	258	GAC	587	589	GAC	204;204;203	G;A;C	186;184;188	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	1	SNP	p	S87I	0	.	.	259	261	AGT	590	592	AGT	202;199;200	A,C;G;T	184,1;185;184	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	1	SNP	p	S87W	0	.	.	259	261	AGT	590	592	AGT	202;199;200	A,C;G;T	184,1;185;184	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	1	SNP	p	S87R	0	.	.	259	261	AGT	590	592	AGT	202;199;200	A,C;G;T	184,1;185;184	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4864	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3089	156.9	1	SNP	p	S88P	0	.	.	262	264	TCC	593	595	TCC	198;199;198	T;C;C	183;184;183	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4326	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2612	165.0	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1579	1581	CAC	187;190;188	C;A;C	176;176;178	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4326	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2612	165.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1528	1530	GGC	212;210;208	G;G;C,T	197;191;189,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1278	1280	GCA	226;226;225	G;C;A	211;208;212	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1281	1283	ATC	228;228;232	A;T,A;C	214;212,1;218	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1293	1295	GTG	226;227;225	G;T;G	210;210;209	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1293	1295	GTG	226;227;225	G;T;G	210;210;209	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1797	1799	ACC	237;235;234	A;C;C	217;218;219	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1851	1853	ACG	203;200;197	A;C;G	164;167;164	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1851	1853	ACG	203;200;197	A;C;G	164;167;164	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1974	1976	GGC	201;203;201	G;G;C	186;187;183	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1983	1985	GGC	195;193;194	G;G;C	179;175;178	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3864	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2414	159.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2001	2003	CTG	180;183;178	C;T,C;GCCC,GCCCC	137;125,1;135,1	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5782	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3111	185.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1595	1597	CCG	227;227;228	C,G;C;G	204,1;212;208	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2310	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1945	118.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	554	554	C	170	C	166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2720	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.7	1	SNP	p	G120K	1	.	.	358	360	AAG	763	765	AAG	211;209;207	A;A;G	198;200;196	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2720	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.7	1	SNP	p	N121D	0	.	.	361	363	AAC	766	768	AAC	209;208;207	A;A;C	196;197;196	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2720	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.7	1	SNP	p	A121N	1	.	.	361	363	AAC	766	768	AAC	209;208;207	A;A;C	196;197;196	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10166	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4930	205.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2023	2025	CAT	236;237;239	C;A;T,A	224;223;224,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1116	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1031	106.9	1	SNP	p	V57M	1	.	.	169	171	ATG	564	566	ATG	219;217;221	A;T;G	209;208;211	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
